BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 68197)

  • 1. Ovarian cysts and hormonal contraception.
    Ylikorkala O
    Lancet; 1977 May; 1(8021):1101-2. PubMed ID: 68197
    [No Abstract]   [Full Text] [Related]  

  • 2. [Risks of contraception: the minipill].
    Keller E
    Ther Umsch; 1986 May; 43(5):392-4. PubMed ID: 3726775
    [No Abstract]   [Full Text] [Related]  

  • 3. [Estroprogestational minipills: breast diseases and functional cysts of the ovary. Apropos of 87 cases].
    Vincens M; de Lignières B; Gompel A
    Therapie; 1985; 40(3):177-80. PubMed ID: 4012662
    [No Abstract]   [Full Text] [Related]  

  • 4. Functional ovarian cysts in relation to the use of monophasic and triphasic oral contraceptives.
    Holt VL; Daling JR; McKnight B; Moore D; Stergachis A; Weiss NS
    Obstet Gynecol; 1992 Apr; 79(4):529-33. PubMed ID: 1553170
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of multiphasic oral contraceptives and hospitalizations of women with functional ovarian cysts in the United States.
    Grimes DA; Hughes JM
    Obstet Gynecol; 1989 Jun; 73(6):1037-9. PubMed ID: 2726107
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Lowering the steroid dose in oral contraception and risk of functional ovarian cysts].
    Mayenga JM; Segard L; Cohen J; Belaïsch-Allart J
    Contracept Fertil Sex; 1995; 23(7-8):439-41. PubMed ID: 7550556
    [No Abstract]   [Full Text] [Related]  

  • 7. Oral contraception and thromboembolism: the role of progestogens.
    N Z Med J; 1980 Aug; 92(665):98, 101. PubMed ID: 6933346
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ovarian and endometrial function during hormonal contraception.
    ESHRE Capri Workshop Group
    Hum Reprod; 2001 Jul; 16(7):1527-35. PubMed ID: 11425842
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ovarian cysts and oral contraceptives.
    Goldzieher JW; Young RL
    Am J Obstet Gynecol; 1989 Feb; 160(2):523-4. PubMed ID: 2916644
    [No Abstract]   [Full Text] [Related]  

  • 10. What is the risk of venous thromboembolism (VTE) among women taking third-generation oral contraceptives (OCs) in comparison with those taking contraceptives containing levonorgestrel?
    Meurer LN; Slawson JG
    J Fam Pract; 2001 Feb; 50(2):108. PubMed ID: 11219554
    [No Abstract]   [Full Text] [Related]  

  • 11. [Contraception and arterial hypertension].
    Corvol P; Millet D; Keledjian P
    Acquis Med Recent; 1977; ():177-80. PubMed ID: 910596
    [No Abstract]   [Full Text] [Related]  

  • 12. [Hormonal contraception and cancer risk].
    Ebeling K; Göretzlehner G
    Z Arztl Fortbild (Jena); 1985; 79(9):365-7. PubMed ID: 4024671
    [No Abstract]   [Full Text] [Related]  

  • 13. Functional ovarian cysts in relation to the use of monophasic and triphasic oral contraceptives.
    Robinson JC
    Obstet Gynecol; 1992 Sep; 80(3 Pt 1):472-3. PubMed ID: 1495708
    [No Abstract]   [Full Text] [Related]  

  • 14. Difference between drospirenone-containing oral contraceptives and other oral contraceptives related to risk of venous thromboembolism.
    Leppée M; Culig J
    J Fam Plann Reprod Health Care; 2012 Apr; 38(2):137-8. PubMed ID: 22454018
    [No Abstract]   [Full Text] [Related]  

  • 15. Oral contraceptives, combined.
    IARC Monogr Eval Carcinog Risks Hum; 1999; 72():49-338. PubMed ID: 10533177
    [No Abstract]   [Full Text] [Related]  

  • 16. Solar urticaria due to progesterone compounds in oral contraceptives.
    Morison WL
    Photodermatol Photoimmunol Photomed; 2003 Jun; 19(3):155-6. PubMed ID: 12914601
    [No Abstract]   [Full Text] [Related]  

  • 17. Is it ethical to use drospirenone-containing combined oral contraceptives?
    Pittrof R
    J Fam Plann Reprod Health Care; 2012 Jul; 38(3):205-6; author reply 206-7. PubMed ID: 22787258
    [No Abstract]   [Full Text] [Related]  

  • 18. [Effects of hormonal contraception on benign changes of the breast].
    De Cecco L; Ragni N; Boccardo E; Viglino S
    Minerva Ginecol; 1982 Nov; 34(11):889-94. PubMed ID: 6818496
    [No Abstract]   [Full Text] [Related]  

  • 19. Third generation oral contraceptives containing desogestrel and gestodene and the risk of thrombosis.
    Griffin JP
    Adverse Drug React Toxicol Rev; 1996 Mar; 15(1):5-7. PubMed ID: 8920631
    [No Abstract]   [Full Text] [Related]  

  • 20. Functional ovarian cysts and oral contraceptives. Negative association confirmed surgically. A cooperative study.
    JAMA; 1974 Apr; 228(1):68-9. PubMed ID: 4406147
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.